Literature DB >> 3101588

Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.

L B Heifets, M D Iseman, P J Lindholm-Levy.   

Abstract

We determined the MICs of ethambutol for both Mycobacterium avium and Mycobacterium tuberculosis strains by using broth dilution (7H12 broth, radiometric method) and agar dilution (7H11 agar) methods. We found the MICs to be much lower in liquid than in solid medium. The broth-determined MICs for susceptible M. tuberculosis and most of the M. avium strains were comparable to the levels in blood of patients, being lower than the peak levels. We propose that the MICs, determined radiometrically in in 7H12 broth, be considered as tentative criteria for susceptibility testing of M. avium isolates in future clinical trials. The use of these values instead of critical concentrations should also be considered as an alternative to the conventional susceptibility testing method in chemotherapy of tuberculosis. Ethambutol produced bactericidal effects against both M. tuberculosis and M. avium, and the MIC/MBC ratios were in the same range for both species when MICs and MBCs were tested in 7H12 broth by conventional sampling and plating.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3101588      PMCID: PMC180621          DOI: 10.1128/AAC.30.6.927

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V.

Authors:  N A KUCK; E A PEETS; M FORBES
Journal:  Am Rev Respir Dis       Date:  1963-06

2.  A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol).

Authors:  J P THOMAS; C O BAUGHN; R G WILKINSON; R G SHEPHERD
Journal:  Am Rev Respir Dis       Date:  1961-06

3.  Studies on the antituberculous activity of ethambutol in monkeys.

Authors:  L H Schmidt
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

4.  Metabolic and special studies of ethambutol in normal volunteers and tuberculous patients.

Authors:  V A Place; E A Peets; D A Buyske; R R Little
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

5.  Comparison of ethambutol-INH versus INH-PAS in original treatment of pulmonary tuberculosis.

Authors:  I D Bobrowitz
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

6.  Influence of the medium on the in vitro susceptibility of Mycobacterium tuberculosis to ethambutol.

Authors:  P R Gangadharam; E R Gonzales
Journal:  Am Rev Respir Dis       Date:  1970-10

7.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors:  G Middlebrook; Z Reggiardo; W D Tigertt
Journal:  Am Rev Respir Dis       Date:  1977-06

8.  Treatment of disease due to Mycobacterium intracellulare.

Authors:  P T Davidson; V Khanijo; M Goble; T S Moulding
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

9.  Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis.

Authors:  J J Tarrand; D H Gröschel
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

10.  Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis.

Authors:  I D Bobrowitz; D E Robins
Journal:  Am Rev Respir Dis       Date:  1967-09
View more
  28 in total

Review 1.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

2.  Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Authors:  S Sreevatsan; K E Stockbauer; X Pan; B N Kreiswirth; S L Moghazeh; W R Jacobs; A Telenti; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis.

Authors:  S V Ramaswamy; A G Amin; S Göksel; C E Stager; S J Dou; H El Sahly; S L Moghazeh; B N Kreiswirth; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 4.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

5.  Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

Authors:  B Madison; B Robinson-Dunn; I George; W Gross; H Lipman; B Metchock; A Sloutsky; G Washabaugh; G Mazurek; J Ridderhof
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages.

Authors:  N Rastogi; V Labrousse; K S Goh; J P De Sousa
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

7.  In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis.

Authors:  Y Miyakawa; P Ratnakar; A G Rao; M L Costello; O Mathieu-Costello; R I Lehrer; A Catanzaro
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.

Authors:  S H Siddiqi; L B Heifets; M H Cynamon; N M Hooper; A Laszlo; J P Libonati; P J Lindholm-Levy; N Pearson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.

Authors:  N Rastogi; K S Goh; H L David
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.

Authors:  G Silve; P Valero-Guillen; A Quemard; M A Dupont; M Daffe; G Laneelle
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.